# Controlling and Lowering Blood Pressure With the MobiusHD™

Study · id `cardio:ct-nct02827032` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02827032](<https://clinicaltrials.gov/study/NCT02827032>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02827032

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

## Technical summary

Registry record NCT02827032. Allocation not applicable; no masking; primary purpose treatment. Start 2016-07 (actual); primary completion 2024-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT02827032, source copy `cardio:ctgov-nct02827032-2023-10-06`, retrieved 2026-10-26)
- Started: 2016-07 (actual) (ClinicalTrials.gov record NCT02827032, source copy `cardio:ctgov-nct02827032-2023-10-06`, retrieved 2026-10-26)
- Primary completion: 2024-12 (anticipated) (ClinicalTrials.gov record NCT02827032, source copy `cardio:ctgov-nct02827032-2023-10-06`, retrieved 2026-10-26)
- Completion: 2026-06 (anticipated) (ClinicalTrials.gov record NCT02827032, source copy `cardio:ctgov-nct02827032-2023-10-06`, retrieved 2026-10-26)
- Countries: Germany; Netherlands; United Kingdom (ClinicalTrials.gov record NCT02827032, source copy `cardio:ctgov-nct02827032-2023-10-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02827032-2023-10-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: Controlling and Lowering Blood Pressure With the MobiusHD™
- Acronym: CALM-DIEM
- Condition: Hypertension
- Intervention (Device): MobiusHD™
- Lead sponsor: Vascular Dynamics, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)

## Provenance

Content hash: 6cd87fecf83a90b44a7deb00b722f857190ca2ff1d33156f5cfcd60816dd4aa8
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
